Replies to post #136329 on Cytodyn Inc (CYDY)

[jimmy667]

It seems like Leronlimab is a broadly active anti-inflammatory.
It is said that inflammation is at the core of many diseases besides NASH. RA ALZ Heart Disease! Don't stop there. But hold the shares forever after the first approval because many more might be coming.

[Black-Ops]

CT Medic, I am not the science type but an idea type.

That's Another story

Lets cover just NASH which by all my research is a slam dunk for CYDY.

84 billion Market

Your 50% is as good as my guess = 42 billion market share

Now I will guess a 50% expense in distribution and 10% to the original holder of the drug. It might be less. 10% works.

Now we are at a lowly 25 billion.

We will need to pay taxes in numerous states although Washington State has zero income taxes.

Lets guess 30% state and Federal Taxes.

Now we are at a miserable 17.5 billion after taxes, although CYDY currently has a huge tax loss carry forward, lets not consider that fact.

Lets assume we have every authorized share issued which includes all the remaining Warrants

800,000,000 shares

every net Billion $$ in after tax Revenues equals 1.25$ per share

That answer is 21.87$ per share in after tax earnings.

100 PE Ratio is easy, maybe 200 PE with exploding earnings.

Walmart did quite well prior to earning 5 cents.

100 X 21$ earnings = 210 per share.

And I am ultra conservative. That's is NASH only.

Cancer is huge. The ordinary flu is huge. Covid? Huge.

CYDY has medical solutions that will hit like a 50 Cal water cooled Browning know as the Saw

The Saw will have a disruptive effect on the shorts. This will be quite a show.


Sleep well shorts